TY - JOUR
T1 - PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation
AU - Johansson, Jeanette A.
AU - Marie, K.L.
AU - Lu, Yuting
AU - Brombin, Alessandro
AU - Santoriello, Cristina
AU - Zeng, Zhiqiang
AU - Zich, Judith
AU - Gautier, Philippe
AU - von Kriegsheim, Alexander
AU - Brunsdon, Hannah
AU - Wheeler, Ann P.
AU - Dreger, Marcel
AU - Houston, Douglas R.
AU - Dooley, Christopher M.
AU - Sims, Andrew H.
AU - Busch-Nentwich, Elisabeth M.
AU - Zon, Leonard I.
AU - Illingworth, Robert S.
AU - Patton, E. Elizabeth
PY - 2020/8/10
Y1 - 2020/8/10
N2 - Melanocytes, replenished throughout life by melanocyte stem cells (MSCs), play a critical role in pigmentation and melanoma. Here, we reveal a function for the metastasis-associated phosphatase of regenerating liver 3 (PRL3) in MSC regeneration. We show that PRL3 binds to the RNA helicase DDX21, thereby restricting productive transcription by RNAPII at master transcription factor (MITF)-regulated endolysosomal vesicle genes. In zebrafish, this mechanism controls premature melanoblast expansion and differentiation from MSCs. In melanoma patients, restricted transcription of this endolysosomal vesicle pathway is a hallmark of PRL3-high melanomas. Our work presents the conceptual advance that PRL3-mediated control of transcriptional elongation is a differentiation checkpoint mechanism for activated MSCs and has clinical relevance for the activity of PRL3 in regenerating tissue and cancer.
AB - Melanocytes, replenished throughout life by melanocyte stem cells (MSCs), play a critical role in pigmentation and melanoma. Here, we reveal a function for the metastasis-associated phosphatase of regenerating liver 3 (PRL3) in MSC regeneration. We show that PRL3 binds to the RNA helicase DDX21, thereby restricting productive transcription by RNAPII at master transcription factor (MITF)-regulated endolysosomal vesicle genes. In zebrafish, this mechanism controls premature melanoblast expansion and differentiation from MSCs. In melanoma patients, restricted transcription of this endolysosomal vesicle pathway is a hallmark of PRL3-high melanomas. Our work presents the conceptual advance that PRL3-mediated control of transcriptional elongation is a differentiation checkpoint mechanism for activated MSCs and has clinical relevance for the activity of PRL3 in regenerating tissue and cancer.
UR - http://dx.doi.org/10.1016/j.devcel.2020.06.013
U2 - 10.1016/j.devcel.2020.06.013
DO - 10.1016/j.devcel.2020.06.013
M3 - Article
SN - 1534-5807
VL - 54
SP - 317-332.E9
JO - Developmental cell
JF - Developmental cell
IS - 3
ER -